MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Resource patients involved in a program of therapeutic education of patients with Parkinson’s disease: contribution to patients’ recruitment

    A.L Ramelli, M.L Fouquet, S. Vasa, P. Simoni, S. Stefanizzi, A. Petit, H. Salhi, G. Fénelon, P.h Remy (Creteil, France)

    Objective: Evaluate the quantitative and qualitative contributions of ‘resource-patients’ (RP) to a Therapeutic Patient Education program (TPE) in Parkinson's disease (PD). Background: TPE is a…
  • MDS Virtual Congress 2020

    Longitudinal association between UPDRS and health-related quality of life in people with Parkinson´s disease

    A. Reyes, L. Rutten-Jacobs, S. Roumpanis, S. Jauss, P. Coloma (Basel, Switzerland)

    Objective: To investigate the longitudinal association of the UPDRS part I (mentation, behavior and mood), UPDRS part II (patient evaluation of activities of daily living…
  • MDS Virtual Congress 2020

    Health care provision and health related quality of life in late stage Parkinson’s disease

    K. Rosqvist, P. Odin, A. Schrag (Lund, Sweden)

    Objective: To describe and assess factors associated with health related quality of life (HRQoL) in late stage Parkinson’s disease (PD), with a special focus on…
  • MDS Virtual Congress 2020

    Comparative analysis of the quality of life between healthy elderly people and those with Parkinson’s disease

    L. Santos, A. Alonso, N. Luna, J. Greve (São Paulo, Brazil)

    Objective: To compare the impact of PD on the quality of life and functioning of the elderly with and without PD. Background: Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Improvement in the handicap is maintained after 5 years of deep brain stimulation in Parkinson’s disease

    D. Silva, M. Fabbri, L. Guedes, A. Caldas, P. Lobo, B. Cattoni, H. Carvalho, A. Ferreira, M. Rosa, J. Ferreira, M. Coelho (Lisbon, Portugal)

    Objective: To characterize the handicap after 4.8 years of DBS-STN and to compare with pre-surgery data. Background: The London Handicap Scale (LHS) provide an overall…
  • MDS Virtual Congress 2020

    Loneliness/Social Isolation as a Risk Factor for Worsened Parkinson Disease Severity

    I. Subramanian, L. Mischley, J. Farahnik (Los Angeles, CA, USA)

    Objective: The goal of this project was to evaluate the association between self-reported loneliness, quality of life, and patient-reported symptoms of Parkinson’s disease (PD) severity.…
  • MDS Virtual Congress 2020

    The Care Partner Perspective: Most Challenging Parkinson’s Symptoms

    A. Wallis, D. Perret (Miami, FL, USA)

    Objective: Our objective is to understand the impact that specific symptoms have on the care partners of people with Parkinson’s, considering gender (of both the…
  • MDS Virtual Congress 2020

    Wilson and Parkinson’s Disease: Beyond Copper Metabolism

    B. Baena Álvarez, R. Sainz Amo, F. Rodríguez Jorge, J. Masjuán Vallejo, J.C Martínez Castillo, A. Celdrán, J. Vaamonde Gamo, J.P Cabello, D. Burgos Santamaría, G. Sánchez Díez, I. Parées Moreno, G. Garcia-Ribas, A. Alonso Cánovas (Madrid, Spain)

    Objective: To show an unusual presentation of Wilson´s disease. Background: Parkinsonism is evident in approximately 40% of patients with Wilson’s disease and responds favourably to…
  • MDS Virtual Congress 2020

    PKAN is associated with significant peripheral metabolic alterations in the Dominican Republic cohort

    C. Bass, F. Middleton, C. Muniz, A. Espinoza, M. Santana Jimenez, S. Baser (Pittsburgh, PA, USA)

    Objective: Applying segmental bioimpedance testing to assess peripheral metabolic alterations in PKAN. Background: PKAN is a rare autosomal recessive disorder with >50 different mutations in…
  • MDS Virtual Congress 2020

    Olfactory impairment in Wilson’s disease

    L.i Chen, X. Wang (Tianjin, China)

    Objective: Olfactory dysfunction is a very common and early sign of many neurodegenerative disorders, but little is known about olfactory dysfunction in Wilson’s disease (WD).…
  • « Previous Page
  • 1
  • …
  • 1159
  • 1160
  • 1161
  • 1162
  • 1163
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley